5th International Conference on Neuroscience and Mental Health

Neuropsychiatry occupies a unique and vital position at the crossroads of neurology and psychiatry, recognising that psychiatric disorders are fundamentally brain disorders, rooted in neurobiological, genetic, and developmental processes that can be studied, understood, and ultimately treated through the lens of neuroscience. This session brings together neuropsychiatrists, neuroscientists, and clinical psychiatrists to explore the brain mechanisms underlying the most complex and challenging psychiatric conditions, from schizophrenia and bipolar disorder to OCD, personality disorders, and beyond. The integration of neuroscience with psychiatric practice is one of the most transformative shifts in modern medicine, and this session is at the forefront of that change.

The advent of advanced neuroimaging, including structural and functional MRI, PET scanning, and EEG-based connectivity analysis, has revolutionised our ability to visualise the brain abnormalities underlying psychiatric conditions, and this session will showcase the most significant findings in this area. Participants will hear about the brain circuit disruptions associated with treatment-resistant depression, the neuroinflammatory underpinnings of psychosis, the genetic architecture of bipolar disorder, and the neural correlates of obsessive-compulsive symptomatology. The move toward precision psychiatry, matching treatments to individual brain-based biomarkers, will be a central and inspiring theme of the session.

Treatment innovation is another major focus of this session. From the expanding applications of neuromodulation therapies, including Electroconvulsive Therapy (ECT), Transcranial Magnetic Stimulation (TMS), and deep brain stimulation, to the latest generation of antipsychotic and mood-stabilising medications, delegates will be exposed to the full range of therapeutic advances transforming neuropsychiatric practice. Early intervention in psychosis, integrated care models for complex psychiatric populations, and the intersection of neuropsychiatry with forensic and liaison psychiatry will further enrich this comprehensive and clinically vital session.

Key Topics:

• Schizophrenia Neurobiology: Brain circuit abnormalities, dopamine dysregulation, neuroinflammation, and genetic factors in schizophrenia.
• Bipolar Disorder: Neuroimaging findings, mood regulation circuits, genetic underpinnings, and advances in pharmacological management.
• Obsessive-Compulsive Disorder: Cortico-striatal-thalamo-cortical circuit dysfunction, neuroimaging biomarkers, and treatment-resistant OCD management.
• Neuroimaging in Psychiatry: How structural and functional brain imaging is transforming psychiatric diagnosis and treatment planning.
• Precision Psychiatry: Biomarker-guided treatment selection, pharmacogenomics, and the move toward personalised psychiatric care.
• Neuromodulation in Psychiatry: Clinical evidence and applications of ECT, TMS, tDCS, and deep brain stimulation for psychiatric conditions.
• Early Psychosis Intervention: The evidence base, clinical models, and long-term outcomes of early intervention programmes for first-episode psychosis.
• Personality Disorders: Neurobiological perspectives on borderline, antisocial, and other personality disorders, and advances in their management.